Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at Congress ...

Rosalind Franklin University of Medicine and Science announced today that BLR Bio, a company in its Helix 51 incubator, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with systemic sclerosis will likely require multidisciplinary management with combination ...

The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com’s ...

Alicia M. Hinze, MD: The goal in therapy for interstitial lung disease that is progressing and systemic sclerosis would be stabilization of disease. Unfortunately, we don’t have something that is ...

Systemic sclerosis is a complex autoimmune condition marked by aberrant immune activation, widespread fibrosis and vasculopathy that affect the skin and multiple internal organs. The disease manifests ...

Fibrosis, or the scaring of tissue, occurs in many diseases, and is a central component of systemic sclerosis. There are currently no treatments that can reverse fibrosis and the current treatment ...

Quantitative assessment of the extent of interstitial lung disease in patients with systemic sclerosis and levels of certain proteins in bronchoalveolar lavage samples have potential for predicting ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and commercialization of drugs for various fibrotic diseases today announced that ...

Although less common than other subtypes of systemic sclerosis (SSc), systemic sclerosis sine scleroderma (ssSSc) makes up more than 8% of SSc cases and "should not be neglected," according to a new ...